Delivery Order SPE2DB20D3103-SPE2DB25FP6Q6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,702.33 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injectors. This firm fixed price, non-set-aside delivery order is scheduled for completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a $93,571.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,573.99 for Zepbound 10 mg/0.5 mL pen injections on May 30, 2025, with completion targeted for June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,827.73 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,571.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injectors. The contract was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and utilizes firm fixed price pricing with no set-aside designation. This delivery order represents a competitively awarded transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors with a ceiling value of $16,361.85. This firm fixed-price contract, which expires August 21, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a delivery order valued at $5,237.35 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $4,273.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with an ultimate completion date of August 18, 2025. This is a non-set-aside competitive award leveraging AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that runs through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,412.99 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price, competitively awarded contract—with no set-aside designation—is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,661.49 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injectors on July 23, 2025. This firm fixed-price delivery order is non-competitive and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with completion scheduled for July 24, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6Q6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,075.15 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is being performed at the vendor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills critical medical procurement needs for federal defense and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. As a prime vendor under the DLA Troop Support Medical contract, the company supplies a wide spectrum of medications across multiple therapeutic domains, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices to support Defense Health Agency operations and other government healthcare customers worldwide. This delivery order for Zepbound, a diabetes and weight management medication, exemplifies the company's role as a key distributor of specialty pharmaceutical products within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/28/25 |